Arkolith/Insider Trading/VIR/Form 4

SB Investment Advisers (UK) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Oct 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$680K
Net Open-Market Flow
-$680K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2025Sell(S)66K$6.05$402K14.6M
Oct 24, 2025Sell(S)47K$5.96$278K14.7M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-019892) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML